Advertisement
Advertisement

XCUR

XCUR logo

Exicure Inc

17.57
USD
-0.96
-5.18%
Dec 18, 14:43 UTC -5
Closed
...

Exicure Inc Profile

About

Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States.

Info & Links

CEO

Paul Kang

Headquarters

2430 N. Halsted St.
Chicago, IL 60614, UNITED STATES

Auditor

Marcum LLP

Share holders

65

Employees

6

Exicure Inc Statistics

Valuation Measures

Market Capitalization2

38.13M

Enterprise Value

37.78M

Enterprise Value/EBITDA(ttm)

-7.09

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

19.39

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-41.45%

Return on Equity(ttm)

-190.90%

Return on Invested Capital(ttm)

-194.43%

Return on Assets(ttm)

-36.75%

Income Statement

Revenue(ttm)

500.00K

Revenue Per Share(ttm)

0.23

Gross Profit(ttm)

500.00K

EBITDA(ttm)3

-5.33M

Net Income Available to Common(ttm)

-4.01M

Diluted EPS(ttm)

-2.07

Share Statistics

Beta (5Y Monthly)

3.66

52-Week Change

778.50%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

2.17M

Dividend Yield

0.00%

Float4

2.39M

% Held by Insiders

8.40%

% Held by Institutions

42.82%

Balance Sheet

Total Cash(mrq)

343.00K

Total Cash Per Share(mrq)

0.16

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.71%

Quick Ratio(mrq)

0.71%

Book Value Per Share(mrq)

0.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.09

Free Cash Flow(ytd)

-2.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement